Evidence map›Paper›PMID 27794019›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2016

Latent Toxoplasma Infection and Higher Toxoplasma gondii Immunoglobulin G Levels Are Associated With Worse Neurocognitive Functioning in HIV-Infected Adults.

Ajay R Bharti, Allen McCutchan, Reena Deutsch, Davey M Smith, Ronald J Ellis, Mariana Cherner, Steven P Woods, Robert K Heaton, Igor Grant, Scott L Letendre

Open access · bronzeAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. Frontiers in psychiatry · 2021
    Review
  4. Article
  5. Article
  6. Article
  7. Toxoplasma: Immunity and Pathogenesis.Current clinical microbiology reports · 2019
    Article
  8. Article
  9. Cognitive Impairment in Zambians With HIV Infection and Pulmonary Tuberculosis.Journal of acquired immune deficiency syndromes (1999) · 2019
    Article
  10. Genital HIV-1 Shedding With Dolutegravir (DTG) Plus Lamivudine (3TC) Dual Therapy.Journal of acquired immune deficiency syndromes (1999) · 2018
    Article
  11. Article
  12. The American journal of tropical medicine and hygiene · 2018
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Ajay R BhartiDepartment of Medicine, University of California, San Diego.
Allen McCutchanDepartment of Medicine, University of California, San Diego.
Reena DeutschDepartment of Psychiatry, University of California, San Diego.
Davey M SmithDepartment of Medicine, University of California, San Diego.
Ronald J EllisDepartment of Neurosciences, University of California, San Diego.
Mariana ChernerDepartment of Psychiatry, University of California, San Diego.
Steven P WoodsDepartment of Psychiatry, University of California, San Diego.
Robert K HeatonDepartment of Psychiatry, University of California, San Diego.
Igor GrantDepartment of Psychiatry, University of California, San Diego.
Scott L LetendreDepartment of Medicine, University of California, San Diego.
University of California, San Diego · US

Funding

STRUCTURAL NEUROIMAGING COREP30MH062512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jessica Lynette Montoya · 2001 to 2026
$50.4M
NEUROMOTORP01DA012065 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LETENDRE, SCOTT L · 1999 to 2009
$17.8M
Impact of HCV Therapy on CNS OutcomesR01DA039775 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BHARTI, AJAY R · 2015 to 2019
$3.0M
Effects of Host and Viral Aging on NeurocognitionR01MH097520 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SMITH, DAVID MITCHELL · 2012 to 2016
$2.0M
Mentoring Clinical Researchers at the Intersection of NeuroHIV and Substance AbuseK24DA040550 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHERNER, MARIANA · 2015 to 2025
$1.8M
Mentoring Translational Research in HIVK24AI100665 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SMITH, DAVID MITCHELL · 2012 to 2021
$1.5M
Neurocognitive Effects of HCV, HIV, and Drug UseR01DA016015 · NIDA · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI LETENDRE, SCOTT L · 2002 to 2004
$1.2M
Midcareer Investigator Award in Patient-Oriented NeuroAIDS ResearchK24MH097673 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LETENDRE, SCOTT L · 2013 to 2017
$917k
Impact of Malaria Co-Infection on HIV-Associated Neurocognitive DisordersK23MH085512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BHARTI, AJAY R · 2010 to 2013
$675k
NIAID NIH HHS K24 AI100665NIDA NIH HHS K24 DA040550NIDA NIH HHS P01 DA012065NIDA NIH HHS R01 DA016015NIDA NIH HHS R01 DA039775NIMH NIH HHS K23 MH085512NIMH NIH HHS K24 MH097673NIMH NIH HHS P30 MH062512NIMH NIH HHS R01 MH097520
6 · The paper itself

Abstract

backgroundHuman immunodeficiency virus (HIV)-associated neurocognitive disorders persist despite suppressive antiretroviral therapy (ART). Because latent Toxoplasma infection (LTI) may adversely impact brain function, we investigated its impact on neurocognitive impairment (NCI) in people living with HIV disease.

methodsTwo hundred sixty-three HIV-infected adults underwent comprehensive neurocognitive assessments and had anti-Toxoplasma gondii immunoglobulin G (anti-Toxo IgG) measured by qualitative and quantitative enzyme-linked immunosorbent assays.

resultsParticipants were mostly middle-aged white men who were taking ART (70%). LTI was detected in 30 (11.4%) participants and was associated with a significantly greater prevalence of global NCI (LTI positive [LTI

conclusionsIn this cross-sectional analysis, LTI was associated with NCI, especially in those with higher CD4

Indexed as

AdultAntibodies, ProtozoanAnti-HIV AgentsBiomarkersCD4 Lymphocyte CountFemaleHIV InfectionsHumansImmunoglobulin GInflammation MediatorsMaleNeurocognitive DisordersPrognosisRisk FactorsToxoplasmaToxoplasmosisAntibodies, ProtozoanAnti-HIV AgentsBiomarkersImmunoglobulin GInflammation MediatorsAnti–Toxoplasma gondii IgGHIV-1 infectionlatent Toxoplasma infectionlatent toxoplasmosisneurocognitive impairment

Identifiers

PMID27794019
PMCPMC5146725
OpenAlexW2541366707

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.